heart attack Archives
Novel genetic study sheds new light on risk of heart attack
Oct. 11, 2018—Loss of a protein that regulates mitochondrial function can greatly increase the risk of myocardial infarction (heart attack), Vanderbilt scientists reported Oct. 3 in the journal eLife.
Gene study spots clues to heart risk for statin patients
May. 3, 2018—A Vanderbilt-led research team has discovered genetic variations that increase the risk of heart attack even when patients are receiving a statin drug like Lipitor or Crestor to lower their blood cholesterol.
Report calls for greater awareness of rare cardiac disease
Apr. 5, 2018—A national effort seeks to raise awareness about an uncommon cause of heart attacks in otherwise healthy, young and middle-aged women.
Cancer immunotherapy drugs linked with more serious heart effects
Mar. 12, 2018—Vanderbilt University Medical Center investigators have identified a growing number of serious and sometimes fatal cases of heart problems among cancer patients treated with some forms of immunotherapy.
New clinic focuses on treating complex arterial disorders
Feb. 23, 2017—When Jessica Biggs first met Esther Kim, M.D., associate professor of Medicine at Vanderbilt, the 33-year-old burst into tears.
Going after the ‘heart attack gremlin’
Sep. 8, 2016—A protein called Gremlin 2 controls the extent of inflammation after heart attack and may be a good therapeutic target.
Uninsured heart attack patients more likely to be transferred to another facility: study
Jun. 9, 2016—A new study finds that uninsured heart attack patients are more likely to be transferred.
Heart repair factor
Sep. 17, 2015—A signaling factor called Wnt10b is a novel target for optimizing cardiac repair after a heart attack.
VUMC recognized for high standard of cardiac care
Aug. 6, 2015—The American College of Cardiology has recognized Vanderbilt University Medical Center (VUMC) for its commitment to and success in implementing a higher standard of care for heart attack patients.
Delivering cells for heart repair
Jul. 10, 2015—A polymer hydrogel material developed by Vanderbilt scientists improved the delivery of stem cells for heart repair.
Target for atherosclerosis therapies
Dec. 17, 2014—A newly identified “atheroprotective” gene is a tool for exploring plaque pathophysiology and may be a good target for therapies to slow atherosclerosis progression.
Study finds national decline in one type of serious heart attack
Nov. 20, 2014—The most emergent form of heart attacks is decreasing nationwide, but this declining incidence could affect emergency departments’ quality and timeliness of care.
